[1] Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies[J]. Diabetologia, 2005, 48(12):2460-2469. [2] Strachan MW, Reynolds RM, Frier BM, et al. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies[J]. Diabetes Obes Metab, 2009, 11(5):407-414. [3] Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function[J]. Arch Neurol, 2004, 61(5):661-666. [4] Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment:current insights[J]. Clin Interv Aging, 2014, 28(9):1011-1019. [5] Spencer JP. The impact of fruit flavonoids on memory and cognition[J]. Br J Nutr, 2010, 104(Suppl 3):S40-S47. [6] 朱蕾. 发酵藤茶黄酮类化学组成及其对糖尿病大鼠血糖、血脂的影响[J]. 湖北民族学院学报(医学版), 2015, 32(1):4-7. [7] 逯凤肖, 郁建平, 秦, 等. 藤茶中二氢杨梅素对糖尿病小鼠血糖和血脂的影响[J]. 山地农业生物学报, 2015, 34(6):89-92. [8] 郝小江, 李玲, 李顺林, 等. 滇产植物乌墨中胰岛素增敏活性成分[J]. 植物资源与环境学报, 2009, 31(5):469-473. [9] Liang J, Lopez-Valdes HE, Martinez-Coria H, et al. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease[J]. Neurochem Res, 2014, 39(6):1171-1181. [10] Liu P, Zou D, Chen K, et al. Erratum to:Dihydromyricetin improves hypobaric hypoxia-induced memory impairment via modulation of SIRT3 signaling[J]. Mol Neurobiol, 2017, 54(3):2373-2374. [11] Besheer J, Bevins RA. Impact of nicotine withdrawal on novelty reward and related behaviors[J]. Behav Neurosci, 2003, 117(2):327-340. [12] Sharma S, Rakoczy S, Brown-Borg H. Assessment of spatial memory in mice[J]. Life Sci, 2010, 87(17-18):521-536. [13] Luchsinger JA, Reitz C, Patel B, et al. Relation of diabetes to mild cognitive impairment[J]. Arch Neurol, 2007, 64(4):570-575. [14] Xu W, Qiu C, Gatz M, et al. Mid-and late-life diabetes in relation to the risk of dementia:a population-based twin study[J]. Diabetes, 2009, 58(1):71-77. [15] Xu W, Caracciolo B, Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes[J]. Diabetes, 2010, 59(11):2928-2935. [16] 杜青,王宇红,赵洪庆,等. 糖尿病并发抑郁症大鼠海马血脑屏障结构的损伤及其机制[J]. 中国应用生理学杂志, 2016, 32(6):558-562. [17] 董倩倩, 陈立峰. 二氢杨梅素药理研究进展[J]. 中南药学, 2005, 3(5):295-298. [18] 要航, 赵彬, 黄燕华, 等. GABA减缓缺氧引起的神经营养素mRNA表达量的变化[J]. 中国应用生理学杂志, 1998, 14(4):289-292. [19] Ying P, Chen L. Neurotrophic factors and diabetic neuropathies in brain[J]. Inter J Endocrinol Metab, 2006, 26(2):119-144. [20] Borah A, Paul R, Choudhury S, et al. Neuroprotective potential of silymarin against CNS disorders:insight into the pathways and molecular mechanisms of action[J]. CNS Neurosci Ther, 2013, 19(11):847-853. |